Does blood glucose control improve vascular outcomes in patients with type 2 diabetes?

被引:0
作者
Robert C. Stanton
机构
来源
Current Diabetes Reports | 2008年 / 8卷
关键词
Gliclazide; Diabetic Kidney Disease; Intensive Control; Intensive Glucose Control; Glycated Hemoglobin Level;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:461 / 463
页数:2
相关论文
共 20 条
[1]  
Boulton A.J.M.(2004)Diabetic somatic neuropathies, technical review Diabetes Care 27 1458-1486
[2]  
Malik R.A.(2005)Diabetic neuropathies: a statement by the American Diabetes Association Diabetes Care 28 955-962
[3]  
Arezzo J.C.(2008)Painful diabetic neuropathy: treatment and future aspects Diabetes Metab Res Rev 24 S52-S57
[4]  
Sosenko J.M.(2005)Diabetic peripheral neuropathy and depressive symptoms: the association revisited Diabetes Care 28 2378-2383
[5]  
Boulton A.J.M.(2008)Treatment of diabetic neuropathy and neuropathic pain: how far have we come? Diabetes Care 31 S255-S261
[6]  
Vinik A.I.(2007)Effects of treatments for symptoms of painful diabetic neuropathy: systematic review BMJ 335 87-90
[7]  
Arezzo J.C.(2007)Duloxetine for the management of diabetic peripheral neuropathic: evidencebased findings from post hoc analysis of 3 multicentre, randomized double blind, placebo controlled, parallel group studies Clin Ther 29 2536-2546
[8]  
Ziegler D.(2007)Emerging drugs in neuropathic pain Expert Opin Emerg Drugs 12 113-126
[9]  
Vileikyte L.(undefined)undefined undefined undefined undefined-undefined
[10]  
Leventhal H.(undefined)undefined undefined undefined undefined-undefined